Your browser doesn't support javascript.
loading
Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1.
Loreto, Andrea; Angeletti, Carlo; Gu, Weixi; Osborne, Andrew; Nieuwenhuis, Bart; Gilley, Jonathan; Merlini, Elisa; Arthur-Farraj, Peter; Amici, Adolfo; Luo, Zhenyao; Hartley-Tassell, Lauren; Ve, Thomas; Desrochers, Laura M; Wang, Qi; Kobe, Bostjan; Orsomando, Giuseppe; Coleman, Michael P.
Afiliação
  • Loreto A; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Angeletti C; Department of Clinical Sciences (DISCO), Section of Biochemistry, Polytechnic University of Marche, Ancona, Italy.
  • Gu W; School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Australia.
  • Osborne A; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Nieuwenhuis B; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Gilley J; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Merlini E; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Arthur-Farraj P; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
  • Amici A; Department of Clinical Sciences (DISCO), Section of Biochemistry, Polytechnic University of Marche, Ancona, Italy.
  • Luo Z; School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Australia.
  • Hartley-Tassell L; Institute for Glycomics, Griffith University, Southport, Australia.
  • Ve T; Institute for Glycomics, Griffith University, Southport, Australia.
  • Desrochers LM; Neuroscience, BioPharmaceuticals R and D, AstraZeneca, Waltham, United States.
  • Wang Q; Neuroscience, BioPharmaceuticals R and D, AstraZeneca, Waltham, United States.
  • Kobe B; School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Australia.
  • Orsomando G; Department of Clinical Sciences (DISCO), Section of Biochemistry, Polytechnic University of Marche, Ancona, Italy.
  • Coleman MP; John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
Elife ; 102021 12 06.
Article em En | MEDLINE | ID: mdl-34870595
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Axônios / Proteínas do Citoesqueleto / Proteínas do Domínio Armadillo / Degeneração Neural / Neurotoxinas Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Axônios / Proteínas do Citoesqueleto / Proteínas do Domínio Armadillo / Degeneração Neural / Neurotoxinas Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article